Difference between revisions of "Team:Edinburgh"
| (4 intermediate revisions by 2 users not shown) | |||
| Line 12: | Line 12: | ||
| − | + | <!-- menu --> | |
<div id="custom-bootstrap-menu" class="navbar navbar-default navbar-fixed-top" role="navigation"> | <div id="custom-bootstrap-menu" class="navbar navbar-default navbar-fixed-top" role="navigation"> | ||
<div class="container-fluid"> | <div class="container-fluid"> | ||
| Line 41: | Line 41: | ||
<li><a href="https://2015.igem.org/Team:Edinburgh/DNPBiosensor">DNP Biosensor</a></li> | <li><a href="https://2015.igem.org/Team:Edinburgh/DNPBiosensor">DNP Biosensor</a></li> | ||
<li><a href="https://2015.igem.org/Team:Edinburgh/PMABiosensor">PMA Biosensor</a></li> | <li><a href="https://2015.igem.org/Team:Edinburgh/PMABiosensor">PMA Biosensor</a></li> | ||
| − | <li><a href="https://2015.igem.org/Team:Edinburgh/CBD">Making it Stick</a></li> | + | <li><a href="https://2015.igem.org/Team:Edinburgh/CBD">Making it Stick</a></li> |
| − | <li><a href="https://2015.igem.org/Team:Edinburgh/Results"> | + | <li><a href="https://2015.igem.org/Team:Edinburgh/Results">Limits of Detection</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 90: | Line 90: | ||
</ul> | </ul> | ||
</li> | </li> | ||
| − | <li><a href="https://2015.igem.org/Team:Edinburgh/MedalCriteria"> | + | <li><a href="https://2015.igem.org/Team:Edinburgh/MedalCriteria">Accomplishments</a></li> |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 120: | Line 120: | ||
<div class="featurette"> | <div class="featurette"> | ||
<img class="featurette-image pull-right" src="https://static.igem.org/mediawiki/2015/7/78/Edigem15_homepage_biosensor.jpg"> | <img class="featurette-image pull-right" src="https://static.igem.org/mediawiki/2015/7/78/Edigem15_homepage_biosensor.jpg"> | ||
| − | <h2 class="featurette-heading">Can SynBIo reduce drug related harm? <span class="muted">We | + | <h2 class="featurette-heading">Can SynBIo reduce drug related harm? <span class="muted">We think this is possible.</span></h2> |
<p class="lead">We're creating a cell-free, paper based biosensor that can provide a semiquantitative analysis of the purity of heroin, as well as test for contaminants in MDMA and diet pills, in order to reduce the likelihood of overdose and illness. </p> | <p class="lead">We're creating a cell-free, paper based biosensor that can provide a semiquantitative analysis of the purity of heroin, as well as test for contaminants in MDMA and diet pills, in order to reduce the likelihood of overdose and illness. </p> | ||
<a href="https://2015.igem.org/Team:Edinburgh/Description" class="btn btn-primary btn-lg outline" role="button">Our Project</a> | <a href="https://2015.igem.org/Team:Edinburgh/Description" class="btn btn-primary btn-lg outline" role="button">Our Project</a> | ||
Latest revision as of 19:00, 20 November 2015
Can SynBIo reduce drug related harm? We think this is possible.
We're creating a cell-free, paper based biosensor that can provide a semiquantitative analysis of the purity of heroin, as well as test for contaminants in MDMA and diet pills, in order to reduce the likelihood of overdose and illness.
Our Project
For our human practices, we have written a story. Check out our timeline to see how each chapter unfolds.
We talked to UK drug policy experts, moral philosophers, end users and many more. Click below to see how we adapted the biology and design of our biosensor in response to their input, and how this process changed our own preconceived notions regarding drug abuse.
Our Story
We've created a page dedicated to explicitly stating where we have fulfilled each medal and special prize requirement on our wiki.
Here, you will find links that direct you to our attempts at fulfilling the criteria for a gold medal, the integrated human practices award and more.
Judging Criteria